Aperio Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $311K | Buy |
12,575
+2,551
| +25% | +$63.1K | ﹤0.01% | 2172 |
|
|
2020
Q3 | $416K | Buy |
10,024
+4,631
| +86% | +$192K | ﹤0.01% | 1916 |
|
|
2020
Q2 | $258K | Buy |
5,393
+370
| +7% | +$17.7K | ﹤0.01% | 2081 |
|
|
2020
Q1 | $316K | Sell |
5,023
-670
| -12% | -$42.2K | ﹤0.01% | 1876 |
|
|
2019
Q4 | $705K | Buy |
5,693
+661
| +13% | +$81.9K | ﹤0.01% | 1625 |
|
|
2019
Q3 | $334K | Buy |
5,032
+186
| +4% | +$12.3K | ﹤0.01% | 1970 |
|
|
2019
Q2 | $386K | Buy |
4,846
+26
| +0.5% | +$2.07K | ﹤0.01% | 1914 |
|
|
2019
Q1 | $539K | Buy |
4,820
+369
| +8% | +$41.3K | ﹤0.01% | 1710 |
|
|
2018
Q4 | $449K | Buy |
4,451
+182
| +4% | +$18.4K | ﹤0.01% | 1744 |
|
|
2018
Q3 | $539K | Sell |
4,269
-28
| -0.7% | -$3.54K | ﹤0.01% | 1724 |
|
|
2018
Q2 | $361K | Sell |
4,297
-835
| -16% | -$70.2K | ﹤0.01% | 1918 |
|
|
2018
Q1 | $316K | Buy |
+5,132
| New | +$316K | ﹤0.01% | 1932 |
|
|
2017
Q3 | – | Sell |
-1,751
| Closed | -$212K | – | 2245 |
|
|
2017
Q2 | $212K | Buy |
+1,751
| New | +$212K | ﹤0.01% | 2075 |
|
|
2016
Q4 | – | Sell |
-2,194
| Closed | -$361K | – | 2139 |
|
|
2016
Q3 | $361K | Buy |
2,194
+263
| +14% | +$43.3K | ﹤0.01% | 1630 |
|
|
2016
Q2 | $276K | Sell |
1,931
-221
| -10% | -$31.6K | ﹤0.01% | 1692 |
|
|
2016
Q1 | $276K | Buy |
2,152
+512
| +31% | +$65.7K | ﹤0.01% | 1701 |
|
|
2015
Q4 | $245K | Buy |
1,640
+350
| +27% | +$52.3K | ﹤0.01% | 1724 |
|
|
2015
Q3 | $214K | Buy |
1,290
+210
| +19% | +$34.8K | ﹤0.01% | 1736 |
|
|
2015
Q2 | $261K | Buy |
+1,080
| New | +$261K | ﹤0.01% | 1719 |
|